Literature DB >> 32428657

Protective effects of extracts from Ephedra foeminea Forssk fruits against oxidative injury in human endothelial cells.

Mohamad Khalil1, Hala Khalifeh2, Fatima Saad2, Nadia Serale3, Annalisa Salis4, Gianluca Damonte4, Giulio Lupidi5, Ahmad Daher2, Laura Vergani6.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Ephedra foeminea is a member of the Ephedraceae family which is widespread in the eastern Mediterranean area. In Lebanon, Ephedra is a popular remedy in traditional medicine to prevent and/or counteract many stress oxidative-related diseases like inflammation and bacterial infections. AIM OF THE STUDY: Oxidative stress leads to endothelial cell dysfunction, and is a major factor contributing to etiology of atherosclerosis and related diseases. This study aims to investigate the antioxidant and cytoprotective potential of extracts from E. foeminea fruits on human endothelial cells exposed to hydrogen peroxide (H2O2) to mimic in vitro vascular endothelium dysfunction.
MATERIALS AND METHODS: Different extracts of E. foeminea fruits were prepared using pure ethanol (EE), methanol/water (EMW), pure hexane (Ehex) or ethyl acetate/water (Epoly) as extraction solvents. The phenolome profile of each extract was characterized using high-performance liquid chromatography coupled with mass spectrometry (HPLC-MS/MS). Total phenolic and flavonoid content, and radical scavenging properties of the extracts were assessed spectrophotometrically. Then, the effects on human endothelial cells HECV were evaluated.
RESULTS: Epoly extract showed the highest phenol and flavonoid content, and the highest radical scavenging capacity. On H2O2-insulted HECV cells Epoly was able: (i) to counteract the ROS/RNS production and lipid peroxidation; (ii) to rescue the ROS-dependent decrease in the mitochondrial membrane potential; (iii) to counteract the apoptosis induction; (iv) to restore endothelial cell viability and migration.
CONCLUSIONS: The findings indicated that the polyphenol-enriched extract Epoly from E. foeminea fruits is endowed with in vitro anti-oxidant and anti-apoptotic effects and might be used as nutraceutical for treating ROS-related endothelium dysfunction and inflammation.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endothelium dysfunction and inflammation; Ephedra foemenia; HPLC/MS; Oxidative stress; Polyphenols

Mesh:

Substances:

Year:  2020        PMID: 32428657     DOI: 10.1016/j.jep.2020.112976

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

1.  Antioxidant and Antihyperglycemic Effects of Ephedra foeminea Aqueous Extract in Streptozotocin-Induced Diabetic Rats.

Authors:  Maha N Abu Hajleh; Khaled M Khleifat; Moath Alqaraleh; Esra'a Al-Hraishat; Muhamad O Al-Limoun; Haitham Qaralleh; Emad A S Al-Dujaili
Journal:  Nutrients       Date:  2022-06-02       Impact factor: 6.706

2.  Untargeted Metabolomic Profiling and Antioxidant Capacities of Different Solvent Crude Extracts of Ephedra foeminea.

Authors:  Ruba Al-Nemi; Arwa A Makki; Khaled Sawalha; Dina Hajjar; Mariusz Jaremko
Journal:  Metabolites       Date:  2022-05-17

3.  Development of a Genus-Universal Nucleotide Signature for the Identification and Supervision of Ephedra-Containing Products.

Authors:  Gang Wang; Xuanjiao Bai; Xiaochen Chen; Ying Ren; Jianping Han
Journal:  Molecules       Date:  2022-04-06       Impact factor: 4.411

4.  New Perspectives of S-Adenosylmethionine (SAMe) Applications to Attenuate Fatty Acid-Induced Steatosis and Oxidative Stress in Hepatic and Endothelial Cells.

Authors:  Laura Vergani; Francesca Baldini; Mohamad Khalil; Adriana Voci; Pietro Putignano; Niccolò Miraglia
Journal:  Molecules       Date:  2020-09-15       Impact factor: 4.411

5.  Shenxian-Shengmai Oral Liquid Improves Sinoatrial Node Dysfunction through the PKC/NOX-2 Signaling Pathway.

Authors:  Heng Zhang; Miao Hao; Lingkang Li; Keyan Chen; Jing Qi; Wei Chen; Xintong Cai; Chen Chen; Zhuang Liu; Ping Hou
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-10       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.